Home    Back

Lactulose/rhamnose solution    (DrugBank: Lactulose, Rhamnose)

2 diseases
IDDisease name (Link within this page)Number of trials
96Crohn disease1
291Hirschsprung disease, entire colon type0

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,209 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03962998
(ClinicalTrials.gov)		October 27, 201922/5/2019Oral Administration of MB-102 Versus Dual Sugar Testing for Gut PermeabilityA Randomized Unblinded Feasibility Study Evaluating the Use of Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability in Normal Subjects and Subjects With Active Small Bowel Crohn's DiseaseCrohn DiseaseDrug: Lactulose/Rhamnose solution;Drug: MB-102MediBeaconNULLRecruiting18 YearsN/AAll20Early Phase 1United States

291. Hirschsprung disease, entire colon type    [ 13 clinical trials,   32 drugs,   (DrugBank: 15 drugs),   0 drug target gene,   0 drug target pathway]
Searched query = "Hirschsprung disease, entire colon type", "Hirschsprung disease, small intestine type", "Hirschsprung disease", "Hirschprung disease", "Hirschsprung disease associated entercolitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 13 trial found